GTS Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
GTS Securities's PFE Position: Q3 2026 in Review
GTS Securities increased its Pfizer (PFE) stake by 248% in Q3 2026, buying an estimated $936K and bringing the position to 49,369 shares worth $1.41M. The position accounts for 0.03% of the portfolio, ranked #393.
GTS Securities first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $41.8M in Q4 2023. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- GTS Securities held 49,369 shares of Pfizer worth $1.41M as of Q3 2026.
- GTS Securities bought 35,193 Pfizer shares in Q3 2026, an estimated $936K.
- Pfizer made up 0.03% of GTS Securities's portfolio in Q3 2026, its #393 holding.
- GTS Securities first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
- GTS Securities's Pfizer position peaked at $41.8M in Q4 2023.
- 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.